An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in ...

A 2024 U.S. national survey reported that 11.8% of males and 7.6% of females ages 12 and older met the criteria for Alcohol ...

CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...

Ever-smokers receiving immunotherapy for gastric and esophageal cancers showed better survival outcomes but higher relapse ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...

Healthcare professionals may use immunotherapy as part of the treatment for someone with Hodgkin’s lymphoma. They may also use it as part of palliative therapy to improve a person’s quality of life ...